News

PeptiDream Partner Asahi Kasei Therapeutics Initiates Phase 1 Clinical Trial for AK1940

2 min

Rznomics RZ-001 Shows 61.5% Response Rate in Hepatocellular Carcinoma Trial at AACR 2026

3 min

Biogen Acquires Felzartamab Rights from TJ Biopharma for Greater China Market

2 min

Argo Biopharma Begins Phase II Trials of BW-40202 siRNA Therapy for Rare Kidney Diseases

2 min

Mabwell Bioscience Passes First PIC/S Member GMP Inspection for Denosumab Biosimilars in Jordan

2 min

Mabwell Subsidiary T-mab Passes Jordan GMP Inspection for Denosumab Biosimilars

2 min

Quality Executive Partners Partners with Vi'eNnI to Expand Virtuosi Training Platform in India's Pharmaceutical Market

2 min

SynSmart and Amporin Partner to Develop Small Molecule Therapeutics for Degenerative Diseases

2 min

Australia's TGA Updates Over-the-Counter Medicine Registration Guidelines for Pharmaceutical Companies

TGA · 2 min

Methylphenidate Shortage Update: Concerta and Ritalin LA Supply Restored, Rubifen LA Expected by June 2026

TGA · 2 min

PMDA Approves Peripheral Rotablator PRO and Visual-ICE Cryoablation System Modifications in Japan

PMDA · 2 min

Alamar Biosciences NASDAQ IPO: Precision Proteomics Company Debuts at $1.5B Valuation

2 min